Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The independent source for health policy research, polling, and news.
2,141-2,160 of 4,001 results
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The whistleblower complaint says that Sutter, one of the largest health systems in the U.S., exaggerated how sick certain Medicare patients were in order to collect higher payments from the government-funded program.
It’s a little-known secret that patients can get thousands of dollars directly from a drugmaker.
To keep costs down, Blue Shield of California next year will scale back on a program allowing members to receive a wide range of care beyond the state’s borders. Customers with individual plans mostly won’t be able to get coverage out of state except for emergencies or other exceptional circumstances.
The price of insulin keeps going up. For people with Type 1 diabetes, high prices can be a life-or-death issue. Now a grass-roots movement is pushing for change.
Breast implants — used for both cancer and cosmetic surgeries — give a glimpse into how hospitals mark up prices of medical devices to increase their bottom lines.
Executive editor Damon Darlin takes a spin as host of "The Friday Breeze," whirling through a week of health care news so you don't have to.
Patient advocates say the state’s new staffing regulations are a good start toward better protecting the frail, but the nursing home industry contends they’re too burdensome.
The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say “wallet biopsies” are common.
The incentive program to discourage nursing homes from discharging patients too quickly will also give bonuses to facilities with fewer rehospitalizations.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Medicare instructs inspectors to look for staffing inadequacies in homes that report suspiciously low numbers of registered nurses and weekend workers.
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
The federal government is issuing bonuses and penalties to skilled nursing facilities based on how often their patients are readmitted to hospitals within a month of being discharged.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Do sales reps in the operating room lend helpful expertise or inflate already bloated costs? Depends on whom you ask.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”
Shereese Hickson’s doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.
A woman had twins in a hospital south of Boston, and for doctors aiming to reduce cesarean sections, the second baby's tricky arrival tested the limits of teamwork.
Policyholders reason that their health is good — for now — and they don’t see the need for costly comprehensive coverage. Detractors say the plans undermine the Affordable Care Act, and agents advise reading the fine print. “You basically have to be in perfect health,” says one.
© 2026 KFF